An interventional study of Aerobic exercise training and Strength training in Sarcopenia, sponsored by Baltimore VA Medical Center. Completed at 2 sites in United States. Open to participants aged 65 Years to 88 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-29.
Sponsored by Baltimore VA Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 187 studies in Sarcopenia with a site in United States — 36 open to participants now, 46 under way, 1 of them phase 3. Sarcopenia · United States.
Among the 187 studies in Sarcopenia with a site in United States, this one is the 126th largest by enrollment of the 146 interventional ones that give a count, is one of 10 that started in 2021, is one of 101 with no phase, and was the 111th registered.
1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.
Browse Sarcopenia studies →36 of the 187 studies in Sarcopenia with a site in United States are open now. Recruiting first, the newest first:
Bettina Mittendorfer · Sites in United States
Ages 18–100 · Healthy volunteers
St. Jude Children's Research Hospital · Sites in United States
Ages 18+ · Healthy volunteers
Ohio State University · Sites in United States
Ages 18+
Kennesaw State University · Sites in United States
Ages 65–85 · Healthy volunteers
Health Discovery Labs · Sites in United States
Ages 18–85
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.
This study: 65 Years to 88 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
187 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 18 · Phase 2 24 · Phase 3 3 · Phase 4 5
First in 1995; this study’s year is marked. 10 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 14 is below the median of 60 across 860 interventional studies indexed under Sarcopenia.
Median enrollment 40 across the 146 interventional studies, 70 across the 40 observational. Of the 127 that completed or were terminated, 44 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 187 have an industry lead sponsor. The 10 most frequent:
Baltimore VA Medical Center is the lead sponsor of 19 studies on the registry; 2 are open to participants now.
Baltimore VA Medical Center has 3 studies filed under Sarcopenia — fewer than ten, so there is no comparison to draw.
17 of the studies in Sarcopenia with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05422534Phase 3Vanderbilt University Medical CenterCoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease | 2027-06-20 |
| NCT07421648SynchroHealth LLCBandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4 | 2026-12 |
| NCT06722508University of California, DavisExercise and Nutritional Prehabilitation for Head and Neck Cancer Patients | 2026-12 |
| NCT07029243University of California, San FranciscoPrehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis | 2026-12 |
| NCT06628349Texas A&M UniversityPrandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 187 studies in Sarcopenia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Aging is associated with a loss of muscle mass, termed sarcopenia, that reduces mobility, decreases physical function and accelerates progression of other age-related disorders. This study is designed to determine whether increasing skeletal muscle capillarization through aerobic exercise will enhance muscular adaptations to strength training in older adults with sarcopenia.
Sarcopenia, or the aging-related loss of muscle mass, affects a large number of older adults. The presence of sarcopenia is associated with physical disability, poor quality of life, and all-cause mortality, in part because sarcopenic adults have low muscle skeletal muscle capillarization and may lack the adequate perfusion needed to maintain muscle mass and function. This study will test the effects of increasing skeletal muscle capillarization through aerobic exercise training on responses to resistance training in older adults. Eligible participants will be randomized to one of two groups, resistance training preceded by aerobic exercise training (AEX-RT), or resistance training followed by aerobic exercise training (RT-AEX). Participants in the AEX-RT group will undergo 3 months of aerobic exercise training to increase skeletal muscle capillarization, followed by 3 months of resistance training. Participants in the RT-AEX group will undergo 3 months of resistance training, followed by 3 months of aerobic exercise training. Before and after the interventions, participants will undergo assessments of muscle size, strength, and capillarization, as well as assessments of physical function.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will undergo 3 months of aerobic exercise training, followed by 3 months of strength training
Other: Aerobic exercise training · Other: Strength training
Participants in this arm will undergo 3 months of strength training, followed by 3 months of aerobic exercise training
Other: Aerobic exercise training · Other: Strength training
3 months of center-based, supervised treadmill exercise
3 months of center-based, supervise strength training
Skeletal Muscle Capillarization
Change in the number of capillaries per unit of skeletal muscle tissue after resistance training. The aims of the study were to compare responses to resistance training between arms/groups. Therefore, only the resistance training-induced change (post minus pre-resistance training) is assessed and analyzed as this is the primary outcome for each arm.
Time frame: 3 months (post minus pre-resistance training)
Quadriceps Muscle Cross-sectional Area
Change in the size of the thigh muscles. The aims of the study were to compare responses to resistance training between arms/groups. Therefore, only the resistance training-induced change (post minus pre-resistance training) is assessed and analyzed as this is the primary outcome for each arm.
Time frame: 3 months (post minus pre-resistance training)
Skeletal Muscle Fiber Size
Change in the cross-sectional size of individual thigh skeletal muscle fibers. The aims of the study were to compare responses to resistance training between arms/groups. Therefore, only the resistance training-induced change (post minus pre-resistance training) is assessed and analyzed as this is the primary outcome for each arm.
Time frame: 3 months (post minus pre-resistance training)
Muscle Strength
Change in the strength/force produced by skeletal muscles of the thigh. Only the resistance training-induced change (post minus pre-resistance training) is reported as this is the primary outcome for each arm.
Time frame: 3 months (post minus pre-resistance training)
| Milestone | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training |
|---|---|---|
| Started | 7 | 7 |
| Completed | 5 | 6 |
| Not completed | 2 | 1 |
| Withdrew: Withdrawal by subject | 2 | 1 |
Change in the number of capillaries per unit of skeletal muscle tissue after resistance training. The aims of the study were to compare responses to resistance training between arms/groups. Therefore, only the resistance training-induced change (post minus pre-resistance training) is assessed and analyzed as this is the primary outcome for each arm.
| capillaries per muscle fiber | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training |
|---|---|---|
| Skeletal Muscle Capillarization | 0.4 ± 0.1 | 0.2 ± 0.1 |
Change in the size of the thigh muscles. The aims of the study were to compare responses to resistance training between arms/groups. Therefore, only the resistance training-induced change (post minus pre-resistance training) is assessed and analyzed as this is the primary outcome for each arm.
| square centimeters | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training |
|---|---|---|
| Quadriceps Muscle Cross-sectional Area | 2.5 ± 2.0 | 0.7 ± 2.6 |
Change in the cross-sectional size of individual thigh skeletal muscle fibers. The aims of the study were to compare responses to resistance training between arms/groups. Therefore, only the resistance training-induced change (post minus pre-resistance training) is assessed and analyzed as this is the primary outcome for each arm.
| square micrometers | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training |
|---|---|---|
| Skeletal Muscle Fiber Size | 607 ± 108 | 356 ± 227 |
Change in the strength/force produced by skeletal muscles of the thigh. Only the resistance training-induced change (post minus pre-resistance training) is reported as this is the primary outcome for each arm.
| Newton-meters | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training |
|---|---|---|
| Muscle Strength | 12.7 ± 2.3 | 2.0 ± 5.8 |
Collected over Data were collected over 6 months of study participation. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Aerobic Exercise Training Followed by Resistance Training | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
| Resistance Training Followed by Aerobic Exercise Training | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
All participants assigned to an intervention are included.
| Age, Categorical(Participants) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 0 | 0 | 0 |
| >=65 years | 7 | 7 | 14 |
| Age, Continuous(years) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| Mean | 78 ± 4 | 73 ± 6 | 75 ± 6 |
| Sex: Female, Male(Participants) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| Female | 4 | 5 | 9 |
| Male | 3 | 2 | 5 |
| Race (NIH/OMB)(Participants) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 1 | 4 | 5 |
| White | 6 | 2 | 8 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 1 | 1 |
| Region of Enrollment(participants) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| United States | 7 | 7 | 14 |
| Appendicular Lean Mass (kg)(kilograms) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| Mean | 17.1 ± 1.9 | 19.3 ± 5.4 | 18.4 ± 4.4 |
| Quadriceps muscle strength (Newton*meters)(Newton*meters) | Aerobic Exercise Training Followed by Resistance Training | Resistance Training Followed by Aerobic Exercise Training | Total |
|---|---|---|---|
| Mean | 91 ± 15 | 107 ± 30 | 101 ± 25 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2021 to primary completion in Apr 2024, 29 months.
Results were first posted in Oct 2025, 1 year 5 months after primary completion.
Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's 29 months is above that.
Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Baltimore VA Medical Center